We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$48.1B
AUM Growth
-$8.01B
Cap. Flow
-$10.9B
Cap. Flow %
-22.65%
Top 10 Hldgs %
28.93%
Holding
6,176
New
664
Increased
1,651
Reduced
2,355
Closed
991

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$92.9M
2
TSLA icon
Tesla
TSLA
+$88.9M
3
MSFT icon
Microsoft
MSFT
+$71.7M
4
AMZN icon
Amazon
AMZN
+$68.5M
5
AZO icon
AutoZone
AZO
+$51.4M

Sector Composition

Rank Sector Weight
1 Technology 3.31%
2 Consumer Discretionary 2.73%
3 Healthcare 2.58%
4 Financials 2.05%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIP icon
5151
ANI Pharmaceuticals
ANIP
$1.86B
-10,849
Closed -$691K
ANSCU
5152
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
-640,000
Closed -$6.59M
ANSCW
5153
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$3.24M
-20,480
Closed -$3.38K
ANTX icon
5154
AN2 Therapeutics
ANTX
$181M
-92,406
Closed -$199K
APAM icon
5155
CALL
Artisan Partners
APAM
$2.86B
-9,000
Closed -$371K
APAM icon
5156
Artisan Partners
APAM
$2.86B
-3,634
Closed -$150K
APAM icon
5157
PUT
Artisan Partners
APAM
$2.86B
-7,700
Closed -$318K
APD icon
5158
Air Products & Chemicals
APD
$65.5B
-740
Closed -$202K
APEI icon
5159
American Public Education
APEI
$940M
-22,492
Closed -$395K
APGE icon
5160
Apogee Therapeutics
APGE
$10.1B
-30,178
Closed -$1.19M
APLS
5161
CALL
DELISTED
Apellis Pharmaceuticals
APLS
-12,800
Closed -$491K
APPN icon
5162
Appian
APPN
$2.11B
-9,256
Closed -$300K
AQST icon
5163
Aquestive Therapeutics
AQST
$452M
-26,892
Closed -$69.9K
ARCT icon
5164
CALL
Arcturus Therapeutics
ARCT
$165M
-10,600
Closed -$258K
ARCT icon
5165
Arcturus Therapeutics
ARCT
$165M
-6,695
Closed -$163K
ARCT icon
5166
PUT
Arcturus Therapeutics
ARCT
$165M
-14,700
Closed -$358K
ARE icon
5167
CALL
Alexandria Real Estate Equities
ARE
$9.37B
-400
Closed -$46.8K
ARE icon
5168
Alexandria Real Estate Equities
ARE
$9.37B
-12,912
Closed -$1.51M
ARE icon
5169
PUT
Alexandria Real Estate Equities
ARE
$9.37B
-2,500
Closed -$292K
ARHS icon
5170
CALL
Arhaus
ARHS
$1.07B
-13,800
Closed -$234K
ARHS icon
5171
Arhaus
ARHS
$1.07B
-1,504
Closed -$25.5K
ARHS icon
5172
PUT
Arhaus
ARHS
$1.07B
-100
Closed -$1.69K
ARGX icon
5173
CALL
argenx
ARGX
$55.2B
-1,500
Closed -$645K
AROC icon
5174
CALL
Archrock
AROC
$6.16B
-16,600
Closed -$336K
ARW icon
5175
CALL
Arrow Electronics
ARW
$10.5B
-2,400
Closed -$290K

Similar funds

Walleye Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Walleye Capital held 6,176 positions worth $48.1B, down 14% from $56.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Walleye Capital withdrew a net $10.9B in Q3 2024, closing 991 positions and reducing 2,355 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $92.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Walleye Capital opened a new position in Cedar Fair worth $35.4M.

  • Walleye Capital's largest Q3 2024 buy was Cedar Fair: 877,543 shares worth $35.4M.
  • Walleye Capital added most to Invesco QQQ Trust in Q3 2024, an estimated $96M increase.
  • Walleye Capital's biggest Q3 2024 reduction was Tesla, cutting an estimated $88.9M.
  • Walleye Capital fully exited iShares 20+ Year Treasury Bond ETF in Q3 2024, selling an estimated $92.9M.
  • Walleye Capital's ten largest holdings make up 29% of its $48.1B portfolio in Q3 2024.
  • Walleye Capital opened 664 new positions and closed 991 in Q3 2024.
  • Walleye Capital's portfolio value fell 14% quarter-over-quarter to $48.1B.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.